Emcure Pharmaceuticals Ltd. Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals Ltd.

EMCURE

Peringkat dalam Saham #4306
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Harga Saham
$19.06
Kapitalisasi Pasar
$3.62B
Perubahan (1 hari)
-1.83%
Perubahan (1 tahun)
20.50%
Negara
IN
Perdagangan Emcure Pharmaceuticals Ltd. (EMCURE)

Kategori

Healthcare
Riwayat pemecahan saham untuk Emcure Pharmaceuticals Ltd. (EMCURE)
Saham Emcure Pharmaceuticals Ltd. (simbol: EMCURE) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Oct 22, 2026.
Satu lembar saham EMCURE yang dibeli sebelum Oct 22, 2026 sekarang setara dengan 0 lembar saham EMCURE.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing